<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05007886</url>
  </required_header>
  <id_info>
    <org_study_id>292396</org_study_id>
    <nct_id>NCT05007886</nct_id>
  </id_info>
  <brief_title>Remote Evaluation of the Naída CI M90 (Marvel) Sound Processor</brief_title>
  <official_title>Remote Evaluation of the Naída CI M90 (Marvel) Sound Processor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cambridge University Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Within-subject comparison. Remotely Evaluating latest Advanced Bionics Marvel Sound Processor&#xD;
      for cochlear implants, from two adult groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Within-subject comparison, standard of care CE marked Advanced Bionics device. Remote&#xD;
      Evaluation of new CI Naida M sound processor through speech understanding in quiet and noise&#xD;
      using standard clinical tests, subjective feedback on sound quality for a set of listening&#xD;
      situations reflecting everyday use and a ease of use questionnaire. Two adult groups, one CI&#xD;
      users and the other bimodal users. All tests completed remotely.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 13, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate difference in speech perception in noise with Naida M (Marvel) and Naida Q hearing devices</measure>
    <time_frame>12 months</time_frame>
    <description>Understanding speech in presence of completing noise and quiet testing remotely through use of Gorilla software. This will be done through a percentage score calculated within the Gorilla software.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in sound clarity and comfort with Naida M (Marvel) device when listening to speech</measure>
    <time_frame>12 months</time_frame>
    <description>Assessment in quiet, background, speech babble, household noises, traffic noise, cafeteria noise and louder alarm signals.This will be done through a measurement of specific questionnaires.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cochlear Hearing Loss</condition>
  <condition>Hearing Loss</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Advanced Bionics cochlear implant users due for a sound processor upgrade in line&#xD;
        with normal standard of care. Able to access the internet and undertake tests remotely.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  CI users with a CI, HiRes90K (Advantage) or HiRes Ultra cochlear implant system&#xD;
&#xD;
          -  Unilaterally implanted recipients using only a Naída Q sound processor&#xD;
&#xD;
          -  Bimodal users: additionally using hearing aid on their contralateral ear&#xD;
&#xD;
               -  Minimum of 18 years of age&#xD;
&#xD;
               -  Minimum of five years' experience with their Naída Q sound processor&#xD;
&#xD;
               -  Minimum of six months experience with their contralateral hearing aid (if&#xD;
                  applicable)&#xD;
&#xD;
               -  Ability to give feedback on sound quality&#xD;
&#xD;
               -  Speech intelligibility with the BKB sentence test in noise at a +10 dB SNR &gt; 10%&#xD;
                  as obtained during previous visits in the clinical routine or BKB &gt;50% in quiet&#xD;
                  conditions if noise has previously not been tested&#xD;
&#xD;
               -  Fluent in English language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Difficulties additional to hearing impairment that would interfere with the study&#xD;
             procedures&#xD;
&#xD;
          -  Concurrent participation in any other clinical hearing study&#xD;
&#xD;
          -  Not due to have their sound processor upgraded in line with normal clinical procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cambridge Biomedical Campus, Addenbrookes Hospital</name>
      <address>
        <city>Cambridge</city>
        <zip>CB2 OQQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 28, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2021</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cambridge University Hospitals NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Sophie McKenny</investigator_full_name>
    <investigator_title>Clinical Researcher</investigator_title>
  </responsible_party>
  <keyword>cochlear implant</keyword>
  <keyword>Advanced Bionics Marvel Processor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

